Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Flutamide for Acne Vulgaris
NCT05478330Completed
- Sponsor
- Zagazig University
- Start
- Jan 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of flutamide in acne vulgaris, sponsored by Zagazig University. Primary endpoints: Number of comedones at 8 weeks and Number of papules at 8 weeks. Started Jan 2021; status: completed.
02
Drugs
flutamide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05478330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05478330.